Tag

NASDAQ: JAZZ

Takeda launches Orzeyful in Japan and China for narcolepsy type 1
Adrian Kessler · Oct 15, 2026
Stoke Therapeutics details Dravet cognition analysis after FDA meeting
Adrian Kessler · Oct 5, 2026
Vanda Pharmaceuticals says Phase III HETLIOZ study met sleep endpoint
Adrian Kessler · Sep 30, 2026